Abeona Therapeutics Inc (ABEO)

NASDAQ
4.6000
-0.1700(-3.56%)
After Hours
4.4100
-0.1900(-4.1304%)
- Real-time Data
  • Volume:
    76,810
  • Day's Range:
    4.5000 - 4.7900
  • 52 wk Range:
    3.2575 - 34.0000

ABEO Overview

Prev. Close
4.77
Day's Range
4.5-4.79
Revenue
4.35M
Open
4.79
52 wk Range
3.2575-34
EPS
-17.57
Volume
76,810
Market Cap
27.37M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
167,267
P/E Ratio
-0.252
Beta
1.05
1-Year Change
-84.27%
Shares Outstanding
5,950,382
Next Earnings Date
13 Nov 2022
What is your sentiment on Abeona Therapeutics?
or
Market is currently closed. Voting is open during market hours.

Abeona Therapeutics Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Abeona Therapeutics Inc Analysis

Abeona Therapeutics Inc Company Profile

Abeona Therapeutics Inc Company Profile

Employees
76

Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company that develops gene and cell therapies for life-threatening rare genetic diseases. The Company’s lead clinical programs consist of EB-101, which is an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa (RDEB) and ABO-102, which is an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A (MPS IIIA). The Company is focused on to develop additional AAV-based gene therapies designed to treat ophthalmic and other diseases and AAV-based gene therapies using the AIM Capsid platform that has a license from the University of North Carolina at Chapel Hill and internal AAV vector research programs. It is applying AIM Capsid Technology to develop in-vivo gene therapies.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyBuyBuyStrong Sell
Technical IndicatorsBuyBuyStrong SellStrong BuyStrong Sell
SummaryBuyBuyNeutralStrong BuyStrong Sell